Skip to main content
OpenTrials
Completed

NCT Number: NCT06301919

Use of N-Butyl Cyanoacrylate in Transarterial Emergency Embolization

NBCA is a synthetic biodegradable cyanoacrylate basis glue, modified by the addition of a monomer with adhesive, hemostatic, and antiseptic properties.

Its use requires a steep learning curve to control emulsification of the NBCA/lipiodol mixture, and injection, to avoid non-target embolization.

The aim of this retrospective monocentric study was to evaluate safety and efficacy of use of NBCA as embolic agent in emergency setting.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Haemostasis Embolisation Disease Attributes Emergencies Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU de Saint-Etienne

Saint-Priest-en-Jarez, 42270, France

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All patients referred to our hospital and treated by TAE with NBCA, based on clinical decisions in emergency and CT scan.

Exclusion criteria

  • Patients lost for follow-up, patients without preoperative CT.

Treatment and study plan

Clinical data

Other

Collecting data from the medical record.

Imaging data

Other

Collecting data from the medical record.

Biological data

Other

Collecting data from the medical record.

Primary outcomes

  1. Evaluation of technical success

    Time frame: Month : 1

    Analysis of angiographic results.

Secondary outcomes

  1. Assessment of clinical success

    Time frame: Month : 1

    Disappearance of signs and symptoms of bleeding during the 30 days of follow-up after WT

  2. Assessment of clinical success

    Time frame: Month : 1

    No endoscopic treatment

  3. Assessment of clinical success

    Time frame: Month : 1

    No surgical intervention

  4. Assessment of clinical success

    Time frame: Month : 1

    No repeat WT

  5. Assessment of clinical success

    Time frame: Month : 1

    Absence of death due to massive blood loss

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Saint Etienne

Other

Registry information

Official study title

Use of N-Butyl Cyanoacrylate in Transarterial Emergency Embolization : a "Real-life" Retrospective Monocentric Study

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Mar 8, 2024
Registry last updated
Jan 27, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.